Magnetic resonance elastography can predict development of hepatocellular carcinoma with longitudinally acquired two-point data.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 25 02 2018
accepted: 29 06 2018
revised: 03 06 2018
pubmed: 26 7 2018
medline: 26 2 2019
entrez: 26 7 2018
Statut: ppublish

Résumé

To evaluate the usefulness of longitudinal observation of liver stiffness measured using magnetic resonance elastography (MRE) to stratify the risk of hepatocellular carcinoma (HCC) in patients with chronic liver disease. We retrospectively reviewed data for 161 patients with chronic liver disease using the following inclusion criteria: two MRE examinations separated by at least a 12-month interval, no history of HCC, no development of HCC between the two examinations and availability of laboratory results. Liver stiffness was classified as low (< 3 kPa), moderate (3-4.7 kPa) or high (> 4.7 kPa). The patients were divided into three groups according to sequential changes in liver stiffness as follows: high on the first MRE (group A, n = 60), low on both MRE examinations (group C, n = 36) and other combinations (group B, n = 65). Cox analyses and Kaplan-Meier methods were used to determine the risk of developing HCC. Forty-seven patients (29.2%) developed HCC during follow-up (46.7% [28/60] in group A, 26.2% [17/65] in group B, and 5.6% [2/36] in group C). There was a significant difference in the rate of development of HCC between groups A (45.1%), B (26.1%) and C (12.4%) at 3 years (p = 0.0002). The independent risk factors for development of HCC were group A classification, age and a high alanine aminotransferase level (risk ratio 1.018-6.030; p = 0.0028-0.0268). Longitudinal observation of liver stiffness using MRE can stratify the risk of HCC during follow-up of chronic liver disease. • The results of MRE can stratify the risk for development of HCC during follow-up in patients with chronic liver disease. • Patients with chronic liver disease and high liver stiffness (> 4.7 kPa) on a previous MRE examination are at high risk for developing HCC, regardless of current liver stiffness. • Management of patients with chronic liver disease becomes more appropriate using longitudinally acquired two-point MRE data.

Identifiants

pubmed: 30043162
doi: 10.1007/s00330-018-5640-7
pii: 10.1007/s00330-018-5640-7
doi:

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1013-1021

Références

Ann Intern Med. 1999 Aug 3;131(3):174-81
pubmed: 10428733
Ann Intern Med. 2000 Apr 4;132(7):517-24
pubmed: 10744587
Med Image Anal. 2001 Dec;5(4):237-54
pubmed: 11731304
J Hepatol. 2006 Jan;44(1):217-31
pubmed: 16298014
Radiology. 2006 Aug;240(2):440-8
pubmed: 16864671
Clin Gastroenterol Hepatol. 2007 Oct;5(10):1207-1213.e2
pubmed: 17916548
J Clin Gastroenterol. 2008 Aug;42(7):839-43
pubmed: 18668703
AJR Am J Roentgenol. 2009 Jul;193(1):122-7
pubmed: 19542403
Liver Int. 2011 Feb;31(2):146-62
pubmed: 21073649
BMC Med Res Methodol. 2011 Apr 04;11:38
pubmed: 21457586
PLoS One. 2012;7(2):e32233
pubmed: 22384189
J Hepatol. 2012 Sep;57(3):556-63
pubmed: 22617153
Eur Radiol. 2013 Jan;23(1):156-62
pubmed: 22814828
J Magn Reson Imaging. 2015 Jan;41(1):117-24
pubmed: 24243628
J Hepatol. 2014 May;60(5):934-9
pubmed: 24362072
Liver Int. 2014 Oct;34(9):1340-8
pubmed: 24620731
J Magn Reson Imaging. 2015 May;41(5):1203-8
pubmed: 24889753
Radiology. 2014 Oct;273(1):88-98
pubmed: 24893048
Expert Rev Gastroenterol Hepatol. 2014 Jul;8(5):501-11
pubmed: 24939348
Invest Radiol. 2015 May;50(5):347-51
pubmed: 25599282
Ann Gastroenterol. 2015 Jan-Mar;28(1):55-65
pubmed: 25608803
J Hepatol. 2015 Sep;63(3):722-32
pubmed: 26026875
Eur Radiol. 2016 Feb;26(2):398-406
pubmed: 26032879
Eur Radiol. 2016 Mar;26(3):656-63
pubmed: 26060066
Radiology. 2016 Jan;278(1):114-24
pubmed: 26162026
Clin Res Hepatol Gastroenterol. 2015 Sep;39 Suppl 1:S104-8
pubmed: 26193870
Hepatol Int. 2015 Oct;9(4):621-6
pubmed: 26208820
Ann Hepatol. 2015 Sep-Oct;14(5):652-7
pubmed: 26256893
Liver Transpl. 2016 Mar;22(3):298-304
pubmed: 26609794
J Magn Reson Imaging. 2016 Sep;44(3):715-22
pubmed: 26929192
Hepatology. 2016 Nov;64(5):1442-1450
pubmed: 27015107
Medicine (Baltimore). 2016 May;95(20):e3434
pubmed: 27196449
Eur Radiol. 2017 Apr;27(4):1713-1721
pubmed: 27456966
Magn Reson Imaging. 2017 Apr;37:41-45
pubmed: 27845245
J Magn Reson Imaging. 2017 Aug;46(2):375-382
pubmed: 27859956
Aliment Pharmacol Ther. 2017 Mar;45(5):744-753
pubmed: 28074540
Hepatology. 2018 Jan;67(1):358-380
pubmed: 28130846
Abdom Radiol (NY). 2017 Jun;42(6):1685-1694
pubmed: 28154910
Jpn J Radiol. 2017 May;35(5):254-261
pubmed: 28357723
Oncology. 2017;93(2):92-98
pubmed: 28448999
Abdom Radiol (NY). 2017 Nov;42(11):2632-2638
pubmed: 28527146
Gastroenterology. 2017 Oct;153(4):996-1005.e1
pubmed: 28642197
Ultrasound Med Biol. 2017 Nov;43(11):2522-2529
pubmed: 28807448
Scand J Gastroenterol. 2017 Dec;52(12):1407-1412
pubmed: 28851259
BMJ Open Gastroenterol. 2018 Mar 20;5(1):e000192
pubmed: 29607053
J Clin Pathol. 1978 May;31(5):395-414
pubmed: 649765

Auteurs

Shintaro Ichikawa (S)

Department of Radiology, University of Yamanashi, 1110 Shimokato, Chuo-shi, Yamanashi, 409-3898, Japan.

Utaroh Motosugi (U)

Department of Radiology, University of Yamanashi, 1110 Shimokato, Chuo-shi, Yamanashi, 409-3898, Japan. umotosugi@nifty.com.

Nobuyuki Enomoto (N)

First Department of Internal Medicine, University of Yamanashi, 1110 Shimokato, Chuo-shi, Yamanashi, 409-3898, Japan.

Hiroshi Onishi (H)

Department of Radiology, University of Yamanashi, 1110 Shimokato, Chuo-shi, Yamanashi, 409-3898, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH